$AMGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMGEN INC. Get notifications about new insider transactions in AMGEN INC for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 27 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2013 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Payment of Exercise | F | 108.66 | 554 | 60,198 | 11,930 | 12.5 K to 11.9 K (-4.44 %) |
Apr 30 2013 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Grant | A | 0.00 | 1,845 | 0 | 12,484 | 10.6 K to 12.5 K (+17.34 %) |
Apr 30 2013 | AMGN | AMGEN INC | ECKERT ROBERT | Director | Grant | A | 0.00 | 1,845 | 0 | 1,845 | 0 to 1.8 K |
Apr 30 2013 | AMGN | AMGEN INC | COFFMAN VANCE D | Director | Grant | A | 0.00 | 1,845 | 0 | 19,637 | 17.8 K to 19.6 K (+10.37 %) |
Apr 30 2013 | AMGN | AMGEN INC | BIONDI FRANK | Director | Grant | A | 0.00 | 1,845 | 0 | 29,780 | 27.9 K to 29.8 K (+6.60 %) |
Apr 30 2013 | AMGN | AMGEN INC | SCOTT DAVID J | SVP, Gen. Counsel & ... | Payment of Exercise | F | 108.38 | 744 | 80,635 | 75,537 | 76.3 K to 75.5 K (-0.98 %) |
Apr 30 2013 | AMGN | AMGEN INC | SCOTT DAVID J | SVP, Gen. Counsel & ... | Payment of Exercise | F | 108.66 | 757 | 82,256 | 76,281 | 77 K to 76.3 K (-0.98 %) |
Apr 30 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,845 | 0 | 32,371 | 30.5 K to 32.4 K (+6.04 %) |
Apr 30 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Option Exercise | M | 50.44 | 10,000 | 504,400 | 0 | |
Apr 30 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Option Exercise | M | 58.43 | 10,000 | 584,300 | 10,000 | |
Apr 30 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Sell | S | 107.02 | 10,000 | 1,070,191 | 54,643 | 64.6 K to 54.6 K (-15.47 %) |
Apr 30 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Buy | M | 50.44 | 10,000 | 504,400 | 64,643 | 54.6 K to 64.6 K (+18.30 %) |
Apr 30 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Payment of Exercise | F | 108.38 | 711 | 77,058 | 54,643 | 55.4 K to 54.6 K (-1.28 %) |
Apr 30 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Payment of Exercise | F | 108.66 | 723 | 78,561 | 55,354 | 56.1 K to 55.4 K (-1.29 %) |
Apr 30 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Sell | S | 107.99 | 10,000 | 1,079,872 | 56,077 | 66.1 K to 56.1 K (-15.13 %) |
Apr 30 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Buy | M | 58.43 | 10,000 | 584,300 | 66,077 | 56.1 K to 66.1 K (+17.83 %) |
Apr 30 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 108.38 | 49 | 5,311 | 15,442 | 15.5 K to 15.4 K (-0.32 %) |
Apr 30 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 108.66 | 50 | 5,433 | 15,491 | 15.5 K to 15.5 K (-0.32 %) |
Apr 30 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 108.38 | 588 | 63,727 | 64,180 | 64.8 K to 64.2 K (-0.91 %) |
Apr 30 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 108.66 | 601 | 65,305 | 64,768 | 65.4 K to 64.8 K (-0.92 %) |
Apr 30 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Payment of Exercise | F | 108.38 | 91 | 9,863 | 16,733 | 16.8 K to 16.7 K (-0.54 %) |
Apr 30 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Payment of Exercise | F | 108.66 | 98 | 10,649 | 16,824 | 16.9 K to 16.8 K (-0.58 %) |
Apr 30 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Grant | A | 0.00 | 942 | 0 | 16,922 | 16 K to 16.9 K (+5.89 %) |
Apr 30 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 426 | 0 | 40,956 | 41.4 K to 41 K (-1.03 %) |
Apr 30 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 426 | 0 | 34,851 | 34.4 K to 34.9 K (+1.24 %) |
Apr 30 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Payment of Exercise | F | 108.38 | 424 | 45,953 | 41,382 | 41.8 K to 41.4 K (-1.01 %) |
Apr 30 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 438 | 0 | 41,806 | 42.2 K to 41.8 K (-1.04 %) |
Apr 30 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 438 | 0 | 34,425 | 34 K to 34.4 K (+1.29 %) |
Apr 30 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Payment of Exercise | F | 108.66 | 437 | 47,484 | 42,244 | 42.7 K to 42.2 K (-1.02 %) |
Apr 30 2013 | AMGN | AMGEN INC | Bradway Robert A | Chairman, President ... | Payment of Exercise | F | 108.38 | 1,566 | 169,723 | 135,379 | 136.9 K to 135.4 K (-1.14 %) |
Apr 30 2013 | AMGN | AMGEN INC | Bradway Robert A | Chairman, President ... | Payment of Exercise | F | 108.66 | 2,349 | 255,242 | 136,945 | 139.3 K to 136.9 K (-1.69 %) |
Apr 29 2013 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 104.93 | 2,721 | 285,515 | 107,312 | 110 K to 107.3 K (-2.47 %) |
Apr 29 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 104.93 | 185 | 19,412 | 15,541 | 15.7 K to 15.5 K (-1.18 %) |
Apr 29 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 104.93 | 1,034 | 108,498 | 65,369 | 66.4 K to 65.4 K (-1.56 %) |
Apr 29 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Payment of Exercise | F | 104.93 | 179 | 18,782 | 15,980 | 16.2 K to 16 K (-1.11 %) |
Apr 29 2013 | AMGN | AMGEN INC | Bradway Robert A | Chairman, President ... | Payment of Exercise | F | 104.93 | 3,617 | 379,532 | 139,294 | 142.9 K to 139.3 K (-2.53 %) |
Apr 29 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 745 | 0 | 42,681 | 43.4 K to 42.7 K (-1.72 %) |
Apr 29 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 745 | 0 | 33,987 | 33.2 K to 34 K (+2.24 %) |
Apr 29 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Payment of Exercise | F | 104.93 | 740 | 77,648 | 43,426 | 44.2 K to 43.4 K (-1.68 %) |
Apr 26 2013 | AMGN | AMGEN INC | SCOTT DAVID J | SVP, Gen. Counsel & ... | Payment of Exercise | F | 104.93 | 1,929 | 202,410 | 77,038 | 79 K to 77 K (-2.44 %) |
Apr 26 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Option Exercise | M | 54.69 | 8,662 | 473,725 | 17,588 | |
Apr 26 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Payment of Exercise | F | 104.93 | 1,234 | 129,484 | 56,077 | 57.3 K to 56.1 K (-2.15 %) |
Apr 26 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Sell | S | 107.95 | 8,662 | 935,029 | 57,311 | 66 K to 57.3 K (-13.13 %) |
Apr 26 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Buy | M | 54.69 | 8,662 | 473,725 | 65,973 | 57.3 K to 66 K (+15.11 %) |
Apr 26 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Gift | G | 0.00 | 1,000 | 0 | 57,311 | 58.3 K to 57.3 K (-1.71 %) |
Apr 26 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Sell | S | 105.95 | 6,924 | 733,565 | 58,311 | 65.2 K to 58.3 K (-10.61 %) |
Mar 19 2013 | AMGN | AMGEN INC | SCOTT DAVID J | SVP, Gen. Counsel & ... | Payment of Exercise | F | 92.18 | 8,647 | 797,080 | 78,967 | 87.6 K to 79 K (-9.87 %) |
Mar 19 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 92.18 | 569 | 52,450 | 15,726 | 16.3 K to 15.7 K (-3.49 %) |
Mar 19 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Payment of Exercise | F | 92.18 | 8,647 | 797,080 | 65,235 | 73.9 K to 65.2 K (-11.70 %) |
Mar 19 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 92.18 | 6,918 | 637,701 | 66,403 | 73.3 K to 66.4 K (-9.44 %) |
Mar 19 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Payment of Exercise | F | 92.18 | 1,121 | 103,334 | 16,159 | 17.3 K to 16.2 K (-6.49 %) |
Mar 19 2013 | AMGN | AMGEN INC | Bradway Robert A | Chairman, President ... | Payment of Exercise | F | 92.18 | 18,046 | 1,663,480 | 142,911 | 161 K to 142.9 K (-11.21 %) |
Mar 19 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 4,754 | 0 | 44,166 | 48.9 K to 44.2 K (-9.72 %) |
Mar 19 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 4,754 | 0 | 33,242 | 28.5 K to 33.2 K (+16.69 %) |
Mar 19 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Payment of Exercise | F | 92.18 | 5,188 | 478,230 | 48,920 | 54.1 K to 48.9 K (-9.59 %) |
Mar 14 2013 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Payment of Exercise | F | 91.75 | 27,540 | 2,526,795 | 93,060 | 120.6 K to 93.1 K (-22.84 %) |
Mar 14 2013 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Option Exercise | M | 54.74 | 10,000 | 547,400 | 10,000 | |
Mar 14 2013 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Payment of Exercise | F | 91.75 | 7,177 | 658,490 | 10,628 | 17.8 K to 10.6 K (-40.31 %) |
Mar 14 2013 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Buy | M | 54.74 | 10,000 | 547,400 | 17,805 | 7.8 K to 17.8 K (+128.12 %) |
Mar 08 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Grant | A | 0.00 | 16,571 | 0 | 73,836 | 57.3 K to 73.8 K (+28.94 %) |
Mar 08 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 13,257 | 0 | 73,238 | 60 K to 73.2 K (+22.10 %) |
Mar 08 2013 | AMGN | AMGEN INC | SCOTT DAVID J | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 16,571 | 0 | 87,555 | 71 K to 87.6 K (+23.34 %) |
Mar 08 2013 | AMGN | AMGEN INC | Bradway Robert A | Chairman, President ... | Grant | A | 0.00 | 34,584 | 0 | 160,755 | 126.2 K to 160.8 K (+27.41 %) |
Mar 08 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 1,514 | 0 | 16,251 | 14.7 K to 16.3 K (+10.27 %) |
Mar 08 2013 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Grant | A | 0.00 | 52,777 | 0 | 120,600 | 67.8 K to 120.6 K (+77.82 %) |
Mar 08 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Grant | A | 0.00 | 9,942 | 0 | 53,922 | 44 K to 53.9 K (+22.61 %) |
Mar 08 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Grant | A | 0.00 | 3,540 | 0 | 17,273 | 13.7 K to 17.3 K (+25.78 %) |
Mar 04 2013 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Payment of Exercise | F | 92.58 | 4,109 | 380,411 | 67,823 | 71.9 K to 67.8 K (-5.71 %) |
Mar 04 2013 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Payment of Exercise | F | 92.58 | 2,889 | 267,464 | 71,932 | 74.8 K to 71.9 K (-3.86 %) |
Mar 01 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 74.89 | 5,000 | 374,450 | 0 | |
Mar 01 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 92.94 | 886 | 82,345 | 30,526 | 31.4 K to 30.5 K (-2.82 %) |
Mar 01 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 91.03 | 4,114 | 374,497 | 31,412 | 35.5 K to 31.4 K (-11.58 %) |
Mar 01 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 74.89 | 5,000 | 374,450 | 35,526 | 30.5 K to 35.5 K (+16.38 %) |
Feb 26 2013 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Option Exercise | M | 74.89 | 5,000 | 374,450 | 0 | |
Feb 26 2013 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Gift | G | 0.00 | 818 | 0 | 3,639 | 2.8 K to 3.6 K (+29.00 %) |
Feb 26 2013 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Gift | G | 0.00 | 818 | 0 | 16,262 | 17.1 K to 16.3 K (-4.79 %) |
Feb 26 2013 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Payment of Exercise | F | 89.55 | 4,182 | 374,498 | 17,080 | 21.3 K to 17.1 K (-19.67 %) |
Feb 26 2013 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Buy | M | 74.89 | 5,000 | 374,450 | 21,262 | 16.3 K to 21.3 K (+30.75 %) |
Feb 11 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Option Exercise | M | 62.55 | 5,000 | 312,750 | 0 | |
Feb 11 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Sell | S | 86.94 | 5,000 | 434,715 | 21,304 | 26.3 K to 21.3 K (-19.01 %) |
Feb 11 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Buy | M | 62.55 | 5,000 | 312,750 | 26,304 | 21.3 K to 26.3 K (+23.47 %) |
Jan 30 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | SVP, Human Resource ... | Grant | A | 0.00 | 4,439 | 0 | 57,265 | 52.8 K to 57.3 K (+8.40 %) |
Jan 30 2013 | AMGN | AMGEN INC | Bradway Robert A | Chairman, President ... | Grant | A | 0.00 | 18,693 | 0 | 126,171 | 107.5 K to 126.2 K (+17.39 %) |
Jan 30 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 7,477 | 0 | 59,981 | 52.5 K to 60 K (+14.24 %) |
Jan 30 2013 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Grant | A | 0.00 | 7,477 | 0 | 109,950 | 102.5 K to 110 K (+7.30 %) |
Jan 30 2013 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Grant | A | 0.00 | 7,477 | 0 | 74,821 | 67.3 K to 74.8 K (+11.10 %) |
Jan 30 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Grant | A | 0.00 | 7,477 | 0 | 43,980 | 36.5 K to 44 K (+20.48 %) |
Jan 30 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 2,103 | 0 | 14,737 | 12.6 K to 14.7 K (+16.65 %) |
Jan 30 2013 | AMGN | AMGEN INC | SCOTT DAVID J | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 5,374 | 0 | 70,984 | 65.6 K to 71 K (+8.19 %) |
Jan 29 2013 | AMGN | AMGEN INC | ECKERT ROBERT | Director | Option Exercise | A | 85.59 | 20,000 | 1,711,800 | 20,000 | |
Dec 20 2012 | AMGN | AMGEN INC | Bradway Robert A | President and CEO | Option Exercise | M | 64.56 | 40,000 | 2,582,400 | 0 | |
Dec 20 2012 | AMGN | AMGEN INC | Bradway Robert A | President and CEO | Payment of Exercise | F | 88.49 | 34,233 | 3,029,278 | 107,478 | 141.7 K to 107.5 K (-24.16 %) |
Dec 20 2012 | AMGN | AMGEN INC | Bradway Robert A | President and CEO | Buy | M | 64.56 | 40,000 | 2,582,400 | 141,711 | 101.7 K to 141.7 K (+39.33 %) |
Dec 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 50.78 | 16,000 | 812,480 | 0 | |
Dec 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 89.00 | 6,800 | 605,220 | 30,526 | 37.3 K to 30.5 K (-18.22 %) |
Dec 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 88.32 | 9,200 | 812,544 | 37,326 | 46.5 K to 37.3 K (-19.77 %) |
Dec 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 50.78 | 16,000 | 812,480 | 46,526 | 30.5 K to 46.5 K (+52.41 %) |
Dec 10 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Option Exercise | M | 50.44 | 5,000 | 252,200 | 0 | |
Dec 10 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Option Exercise | M | 42.13 | 5,000 | 210,650 | 0 | |
Dec 10 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Option Exercise | M | 62.55 | 5,000 | 312,750 | 0 | |
Dec 10 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Sell | S | 87.92 | 15,000 | 1,318,830 | 16,329 | 31.3 K to 16.3 K (-47.88 %) |
Dec 10 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Buy | M | 50.44 | 5,000 | 252,200 | 31,329 | 26.3 K to 31.3 K (+18.99 %) |
Dec 10 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Buy | M | 42.13 | 5,000 | 210,650 | 26,329 | 21.3 K to 26.3 K (+23.44 %) |
Dec 10 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Buy | M | 62.55 | 5,000 | 312,750 | 21,329 | 16.3 K to 21.3 K (+30.62 %) |
Nov 29 2012 | AMGN | AMGEN INC | BIONDI FRANK | Director | Option Exercise | M | 74.89 | 5,000 | 374,450 | 0 | |
Nov 29 2012 | AMGN | AMGEN INC | BIONDI FRANK | Director | Sell | S | 88.10 | 5,000 | 440,512 | 27,833 | 32.8 K to 27.8 K (-15.23 %) |
Nov 29 2012 | AMGN | AMGEN INC | BIONDI FRANK | Director | Buy | M | 74.89 | 5,000 | 374,450 | 32,833 | 27.8 K to 32.8 K (+17.96 %) |
Nov 26 2012 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Option Exercise | M | 62.55 | 5,000 | 312,750 | 0 | |
Nov 26 2012 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Option Exercise | M | 74.89 | 5,000 | 374,450 | 0 | |
Nov 26 2012 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Option Exercise | M | 50.78 | 16,000 | 812,480 | 0 | |
Nov 26 2012 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Sell | S | 87.11 | 26,000 | 2,264,985 | 176,783 | 202.8 K to 176.8 K (-12.82 %) |
Nov 26 2012 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Buy | M | 62.55 | 5,000 | 312,750 | 202,783 | 197.8 K to 202.8 K (+2.53 %) |
Nov 26 2012 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Buy | M | 74.89 | 5,000 | 374,450 | 197,783 | 192.8 K to 197.8 K (+2.59 %) |
Nov 26 2012 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Buy | M | 50.78 | 16,000 | 812,480 | 192,783 | 176.8 K to 192.8 K (+9.05 %) |
Oct 29 2012 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 87.63 | 11,671 | 1,022,730 | 102,438 | 114.1 K to 102.4 K (-10.23 %) |
Oct 29 2012 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 87.63 | 367 | 32,160 | 12,607 | 13 K to 12.6 K (-2.83 %) |
Oct 29 2012 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 5,420 | 0 | 12,974 | 7.6 K to 13 K (+71.75 %) |
Oct 26 2012 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Gift | G | 0.00 | 8,572 | 0 | 176,783 | 185.4 K to 176.8 K (-4.62 %) |
Oct 26 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Gift | G | 0.00 | 4,074 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
Oct 26 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Gift | G | 0.00 | 1,420 | 0 | 4,074 | 5.5 K to 4.1 K (-25.85 %) |
Oct 25 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Option Exercise | M | 71.88 | 193,609 | 13,916,615 | 0 | |
Oct 25 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Option Exercise | M | 71.88 | 1,391 | 99,985 | 0 | |
Oct 25 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Sell | S | 88.72 | 27,505 | 2,440,249 | 5,494 | 33 K to 5.5 K (-83.35 %) |
Oct 25 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Sell | S | 88.06 | 235,495 | 20,738,349 | 32,999 | 268.5 K to 33 K (-87.71 %) |
Oct 25 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Gift | G | 0.00 | 195,000 | 0 | 101,018 | 296 K to 101 K (-65.87 %) |
Oct 25 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Gift | G | 0.00 | 195,000 | 0 | 268,494 | 73.5 K to 268.5 K (+265.33 %) |
Oct 25 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Buy | M | 71.88 | 193,609 | 13,916,615 | 296,018 | 102.4 K to 296 K (+189.05 %) |
Oct 25 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Buy | M | 71.88 | 1,391 | 99,985 | 102,409 | 101 K to 102.4 K (+1.38 %) |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Option Exercise | M | 58.43 | 79,625 | 4,652,489 | 159,250 | |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Option Exercise | M | 62.55 | 193,402 | 12,097,295 | 0 | |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Option Exercise | M | 62.55 | 1,598 | 99,955 | 0 | |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Sell | S | 83.97 | 24,415 | 2,050,042 | 73,494 | 97.9 K to 73.5 K (-24.94 %) |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Sell | S | 83.96 | 50,585 | 4,247,314 | 97,909 | 148.5 K to 97.9 K (-34.07 %) |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Sell | S | 83.96 | 274,625 | 23,058,009 | 148,494 | 423.1 K to 148.5 K (-64.90 %) |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Gift | G | 0.00 | 274,625 | 0 | 101,018 | 375.6 K to 101 K (-73.11 %) |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Gift | G | 0.00 | 274,625 | 0 | 423,119 | 148.5 K to 423.1 K (+184.94 %) |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Buy | M | 58.43 | 79,625 | 4,652,489 | 375,643 | 296 K to 375.6 K (+26.90 %) |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Buy | M | 62.55 | 193,402 | 12,097,295 | 296,018 | 102.6 K to 296 K (+188.47 %) |
Sep 12 2012 | AMGN | AMGEN INC | SHARER KEVIN W | Director | Buy | M | 62.55 | 1,598 | 99,955 | 102,616 | 101 K to 102.6 K (+1.58 %) |
Aug 31 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Option Exercise | M | 74.89 | 5,000 | 374,450 | 0 | |
Aug 31 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Sell | S | 83.25 | 5,000 | 416,254 | 16,316 | 21.3 K to 16.3 K (-23.46 %) |
Aug 31 2012 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Buy | M | 74.89 | 5,000 | 374,450 | 21,316 | 16.3 K to 21.3 K (+30.64 %) |
Aug 27 2012 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Option Exercise | M | 74.89 | 5,000 | 374,450 | 0 | |
Aug 27 2012 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Sell | S | 84.37 | 5,000 | 421,833 | 21,304 | 26.3 K to 21.3 K (-19.01 %) |
Aug 27 2012 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Buy | M | 74.89 | 5,000 | 374,450 | 26,304 | 21.3 K to 26.3 K (+23.47 %) |
Aug 13 2012 | AMGN | AMGEN INC | REASON J PAUL | Director | Sell | S | 81.93 | 4,500 | 368,692 | 23,591 | 28.1 K to 23.6 K (-16.02 %) |
Aug 08 2012 | AMGN | AMGEN INC | REASON J PAUL | Director | Option Exercise | M | 54.69 | 5,000 | 273,450 | 0 | |
Aug 08 2012 | AMGN | AMGEN INC | REASON J PAUL | Director | Option Exercise | M | 58.43 | 5,000 | 292,150 | 0 | |
Aug 08 2012 | AMGN | AMGEN INC | REASON J PAUL | Director | Option Exercise | M | 50.44 | 5,000 | 252,200 | 0 | |
Aug 08 2012 | AMGN | AMGEN INC | REASON J PAUL | Director | Option Exercise | M | 42.13 | 5,000 | 210,650 | 0 |